Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel.
Zakria D, Brownstone N, Armstrong AW, Boh EE, Koo JYM, Merola JF, Pariser D, Lebwohl M. Zakria D, et al. Among authors: armstrong aw. J Drugs Dermatol. 2023 Jun 1;22(6):588-593. doi: 10.36849/JDD.7432. J Drugs Dermatol. 2023. PMID: 37276166
Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology and choose the optimal medication through a targeted and evidence-based approach. Zakria D, Brownstone N, Armstrong AW, et al. I …
Utilizing precision medicine tests such as Mind.Px can help providers identify biomarkers unique to a patient’s pathophysiology an …
Brodalumab: 4-Year US Pharmacovigilance Report.
Lebwohl M, Koo J, Leonardi C, Armstrong A, Rawnsley N, Goehring E, Jacobson A. Lebwohl M, et al. J Drugs Dermatol. 2023 Apr 1;22(4):419-422. doi: 10.36849/JDD.7344. J Drugs Dermatol. 2023. PMID: 37026879
Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis.
Armstrong AW, Reddy R, Khan S, Chovatiya R, Green L, Gold LS, Kwong P, Lebwohl M, Kircik L. Armstrong AW, et al. J Drugs Dermatol. 2023 Aug 1;22(8):736-741. doi: 10.36849/jdd.7453. J Drugs Dermatol. 2023. PMID: 37556522
These recommendations will be continuously reviewed and updated as more evidence continues to emerge.  April W. Armstrong AW, Reddy R, Khan S, et al. Consensus statements on the use of corticosteroid-containing topical medications in psoriasis. ...
These recommendations will be continuously reviewed and updated as more evidence continues to emerge.  April W. Armstrong …
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, Weinberg JM, Kircik L, Han G, Langley RG, Neimann AL, Lebwohl M. Burshtein J, et al. Among authors: armstrong aw. J Drugs Dermatol. 2024 Aug 1;23(8):592-599. doi: 10.36849/JDD.8246. J Drugs Dermatol. 2024. PMID: 39093660 Review.
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting.
Zhang AJ, Ball G, Zundell MP, Agüero R, Yee D, Shields A, Asare C, Navrazhina K, Liu W, Foolad N, Kwock J, Tejwani P, Hamade H, Jaleel T, Butler D, Silverberg N, Nattkemper L, Siegel DM, Tan J, Kim BS, Larocca C, Shinohara MM, Ehlert A, Latella J, Guttman-Yassky E, Krueger JG, Strand V, Armstrong AW, Merola JF, Perez-Chada L, Gottlieb AB. Zhang AJ, et al. Among authors: armstrong aw. J Drugs Dermatol. 2024 Dec 1;23(12):1114-1120. doi: 10.36849/jdd.8363. J Drugs Dermatol. 2024. PMID: 39630678
Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
Kim BS, Bissonnette R, Nograles K, Munera C, Shah N, Jebara A, Cirulli J, Goncalves J, Lebwohl M; KOMFORT Trial Investigators. Kim BS, et al. N Engl J Med. 2023 Feb 9;388(6):511-517. doi: 10.1056/NEJMoa2210699. N Engl J Med. 2023. PMID: 36780675 Clinical Trial.
511 results